Skip to main content
SpringerLink
Log in

Prevalence of autoantibodies against 3-DG-glycated H2A protein in type 2 diabetes

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

Advanced glycation end-products (AGEs) have been found to be critically involved in initiation or progression of diabetes secondary complications (nephropathy, retinopathy, neuropathy, and angiopathy). Various hyper-glycating carbonyl compounds such as 3-deoxyglucosone (3-DG) are produced in pathophysiological conditions that form AGEs in high quantity both in vivo and in vitro. In the first stage of this study, we glycated histone H2A protein by 3-DG, and the results showed the formation of various intermediates and AGEs as well as structural changes in the protein. In the second stage, we studied the immunogenicity of native and 3-DG-glycated H2A protein in female rabbits. The modified H2A was highly immunogenic, eliciting high titer immunogen-specific antibodies, while the unmodified form was almost nonimmunogenic. Antibodies against standard carboxymethyllysine (CML) and pentosidine were detected in the immunized female rabbits, which demonstrates the immunogenic nature of AGEs (CML and pentosidine) as well. The results show both structural perturbation and AGEs have the capacity of triggering the immune system due to the generation of neoepitopes that render the molecule immunogenic. This study shows the presence of autoantibodies against 3-DG-modified H2A, CML, and pentosidine in the sera of type 2 diabetes patients having secondary complications. Autoantibodies against damaged H2A and AGEs may be significant in the assessment of initiation/progression of secondary complications in type 2 diabetes mellitus patients or may be used as a marker for early detection of secondary complications in diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AGEs:

advanced glycation end-products

CML:

carboxymethyllysine

3-DG:

3-deoxyglucosone

References

  1. Singh, R., Barden, A., Mori, T., and Beilin, L. (2001) Advanced glycation endproducts: a review, Diabetologia, 44, 129–146.

    Article  CAS  PubMed  Google Scholar 

  2. Njoroge, F. G., and Monnier, V. M. (1989) The chemistry of the Maillard reaction under physiological conditions: a review, Prog. Clin. Biol. Res., 304, 85–107.

    CAS  PubMed  Google Scholar 

  3. Ahmad, S., Moinuddin, Dixit, K., Shahab, U., Alam, K., and Ali, A. (2011) Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+, Biochem. Biophys. Res. Commun., 407, 568–574.

    Article  CAS  PubMed  Google Scholar 

  4. Brownlee, M. (1992) Glycation products and pathogenesis of diabetic complications, Diabetes Care, 15, 1835–1843.

    Article  CAS  PubMed  Google Scholar 

  5. Bucala, R., Cerami, A., and Vlassara, H. (1995) Advanced glycosylation end products in diabetic complications, Diabetes Rev., 3, 258–268.

    Google Scholar 

  6. Chappey, O., Dosquet, C., Wautier, M. P., and Wautier, J. L. (1997) Advanced glycation endproducts, oxidant stress and vascular lesions, Eur. J. Clin. Invest., 27, 97–108.

    Article  CAS  PubMed  Google Scholar 

  7. Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferucci, L., Striker, G., and Vlassara, H. (2007) Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress and aging, J. Gerontol. A Biol. Sci. Med. Sci., 62, 427–433.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Jr., Chow, W. S., Stern, D., and Schmidt, A. M. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products, Nat. Med., 4, 1025–1031.

    Article  CAS  PubMed  Google Scholar 

  9. McLellan, A. C., Thornalley, P. J., Benn, J., and Sonksen, P. H. (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications, Clin. Sci., 87, 21–29.

    Article  CAS  PubMed  Google Scholar 

  10. Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T., and Uchida, K. (1999) Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxalarginine adducts, J. Biol. Chem., 274, 18492–18502.

    Article  CAS  PubMed  Google Scholar 

  11. Frye, E. B., Degenhardt, T. P., Thorpe, S. P., and Baynes, J. B. (1998) Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end productdependent increase in imidazolium crosslinks in human lens proteins, J. Biol. Chem., 273, 18714–18719.

    Article  CAS  PubMed  Google Scholar 

  12. Thornalley, P. J., Langborg, A., and Minhas, H. S. (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose, Biochem. J., 344, 109–116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Choudhary, D., Chandra, D., and Kale, R. K. (1997) Influence of methylglyoxal on antioxidant enzymes and oxidative damage, Toxicol. Lett., 93, 141–152.

    Article  CAS  PubMed  Google Scholar 

  14. Ashraf, J. M., Arif, B., Dixit, K., Moinuddin, and Alam, K. (2012) Physicochemical analysis of structural changes in DNA modified with glucose, Int. J. Biol. Macromol., 51, 604–611.

    Article  CAS  PubMed  Google Scholar 

  15. Festa, A., Schmolzer, B., Schernthaner, G., and Menzel, E. J. (1998) Differential expression of receptors for advanced glycation endproducts on monocytes in patients with IDDM, Diabetologia, 41, 674–680.

    Article  CAS  PubMed  Google Scholar 

  16. Wolffe, A. (1998) Chromatin. Structure and Function, Academic Press, San Diego, p. 447.

    Google Scholar 

  17. Liebich, H. M., Gesele, E., Wirth, C., Woll, J., Jobst, K., and Lakatos, A. (1992) Nonenzymatic glycation of histones, Biol. Mass Spectrom., 22, 121–123.

    Article  Google Scholar 

  18. Gugliucci, A. (1994) Advanced glycation of rat liver histone octamers: an in vitro study, Biochem. Biophys. Res. Commun., 203, 588–593.

    Article  CAS  PubMed  Google Scholar 

  19. Cervantes-Laurean, D., Jacobson, E. L., and Jacobson, M. K. (1996) Glycation and glycoxidation of histones by ADP-ribose, J. Biol. Chem., 271, 10461–10469.

    Article  CAS  PubMed  Google Scholar 

  20. Gugliucci, A., and Bendayan, M. (1995) Histones from diabetic rats contain increased levels of advanced glycation end products, Biochem. Biophys. Res. Commun., 212, 56–62.

    Article  CAS  PubMed  Google Scholar 

  21. Bojanovic, J. J., Jevtovic, A. D., Pantic, V. S., Dugandzic, S. M., and Jovanovic, D. S. (1970) Thymus nucleoproteins. Thymus histones in young and adult rats, Gerontologia (Basel), 16, 304–312.

    Article  CAS  Google Scholar 

  22. Turk, Z., Ljubica, S., Turk, N., and Benko, B. (2001) Detection of autoantibodies against advanced glycation end products and AGE-immune complexes in serum of patients with diabetes mellitus, Clin. Chim. Acta, 303, 105–115.

    Article  CAS  PubMed  Google Scholar 

  23. Makino, H., Shikata, K., Hironaka, K., Kushiro, M., Yamasaki, Y., Sugimoto, H., Ota, Z., Araki, N., and Horiuchi, S. (1995) Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy, Kid. Int., 48, 517–526.

    Article  CAS  Google Scholar 

  24. Ansari, N. A., Moinuddin, Alam, K., and Ali, A. (2009) Preferential recognition of Amadoririch lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process, Hum. Immunol., 70, 417–424.

    Article  CAS  PubMed  Google Scholar 

  25. Ansari, N. A., and Dash, D. (2013) Biochemical studies on methylglyoxal mediated glycated histones: implications for presence of serum antibodies against the glycated histones in patients with type 1 diabetes mellitus, ISRN Biochem., 198065.

    Google Scholar 

  26. Ashraf, J. M., Ahmad, S., Rabbani, G., Jan, A. T., Lee, E. J., Khan, R. H., and Choi, I. (2014) Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone, IUBMB Life, 66, 686–693.

    Article  CAS  PubMed  Google Scholar 

  27. Ashraf, J. M., Arfat, M. Y., Arif, Z., Ahmad, J., Moinuddin, and Alam, K. (2015) A clinical correlation of anti-DNA-AGE autoantibodies in type 2 diabetes mellitus with disease duration, Cell Immunol., 293, 74–79.

    Article  CAS  PubMed  Google Scholar 

  28. Shahab, U., Moinuddin, Ahmad, S., Dixit, K., and Ali, A. (2013) Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: implications in bladder cancer, PLoS One, 8, e53205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Moinuddin, Dixit, K., Ahmad, S., Shahab, U., Alam, K., and Ali, A. (2014) Human DNA damage by the synergistic action of 4-aminobiphenyl and nitric oxide: an immunochemical study, Environ. Toxicol., 29, 568–576.

    Article  CAS  PubMed  Google Scholar 

  30. Alam, K., Moinuddin, and Jabeen, S. (2007) Immunogenicity of mitochondrial DNA modified by hydroxyl radical, Cell Immunol., 247, 12–17.

    Article  CAS  PubMed  Google Scholar 

  31. Ashraf, J. M., Rabbani, G., Ahmad, S., Hasan, Q., Khan, R. H., Alam, K., and Choi, I. (2015) Glycation of H1 histone by 3-deoxyglucosone: effects on protein structure and generation of different advanced glycation end products, PLoS One, 10, e0130630.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ashraf, J. M., Ahmad, S., Rabbani, G., Hasan, Q., Jan, A. T., Lee, E. J., and Choi, I. (2015) 3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs, PLoS One, 10, e0116804.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Arfat, M. Y., Ashraf, J. M., Arif, Z., Moinuddin, and Alam, K. (2014) Fine characterization of glucosylated human IgG by biochemical and biophysical methods, Int. J. Biol. Macromol., 69, 408–415.

    Article  CAS  PubMed  Google Scholar 

  34. Akhter, F., Khan, M. S., Singh, S., and Ahmad, S. (2014) An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated lowdensity lipoprotein, PLoS One, 9, e113144.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Turk, Z., Ljubica, S., Turk, N., and Benko, B. (2001) Detection of autoantibodies against advanced glycation end products and AGE-immune complexes in serum of patients with diabetes mellitus, Clin. Chim. Acta, 303, 105–115.

    Article  CAS  PubMed  Google Scholar 

  36. Mustafa, I., Ahmad, S., Dixit, K., Moinuddin, Ahmad, J., and Ali, A. (2012) Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetes mellitus patients, Diabetes Res. Clin. Prac., 95, 98–104.

    Article  CAS  Google Scholar 

  37. Nagai, R., Fujiwara, Y., Mera, K., Yamagata, K., Sakashita, N., and Takeya, M. (2008) Immunochemical detection of N epsilon-(carboxyethyl)lysine using a specific antibody, J. Immunol. Methods, 332, 112–120.

    Article  CAS  PubMed  Google Scholar 

  38. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., and Horiuchi, S. (1996) Nε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, Biochemistry, 35, 8075–8083.

    Article  CAS  PubMed  Google Scholar 

  39. Reddy, S., Bichler, J., Wells-Knecht, K. J., Thorpe, S. R., and Baynes, J. W. (1995) Nε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins, Biochemistry, 34, 10872–10878.

    Article  CAS  PubMed  Google Scholar 

  40. Shibayama, R., Araki, N., Nagai, R., and Horiuchi, S. (1999) Autoantibody against Nε-carboxymethyllysine: an advanced glycation end product of the Maillard reaction, Diabetes, 48, 1842–1829.

    Article  CAS  PubMed  Google Scholar 

  41. Ahmad, S., Moinuddin, Habib, S., Shahab, U., Alam, K., and Ali, A. (2014) Autoimmune response to AGE modified human DNA: implications in type 1 diabetes mellitus, J. Clin. Trans Endo, 1, 66–72.

    CAS  Google Scholar 

  42. Ahmad, S. (2014) Immunogenicity of DNA damage by free radicals and carbonyls: a probable biomarker for the autoimmune diseases, J. Immun. Res., 1, 2.

    Google Scholar 

  43. Shahab, U., Tabrez, S., Khan, M. S., Akhter, F., Khan, M. S., Saeed, M., Ahmad, K., Srivastava, A. K., and Ahmad, S. (2014) Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: its potential role in prompt recognition of diabetes mellitus autoantibodies, Chem. Biol. Int., 219, 229–240.

    Article  CAS  Google Scholar 

  44. Ahmad, S., Moinuddin, Shahab, U., Khan, M. S., Habeeb, S., Alam, K., and Ali, A. (2014) Glycooxidative damage to human DNA-neoantigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes, Glycobiology, 24, 281–291.

    Article  CAS  PubMed  Google Scholar 

  45. Akhter, F., Khan, M. S., Abdulrahman, A. A., Faisal, M., and Ahmad, S. (2016) Antigenic role of the adaptive immune response to D-ribose glycated LDL in diabetes, atherosclerosis and diabetic atherosclerosis patients, Life Sci., 151, 139–146.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia

    J. M. Ashraf, S. M. S. Abdullah, A. M. Madkhali & A. B. A. Jerah

  2. Department of Biotechnology, Integral University, Lucknow, India

    S. Ahmad

  3. Faculty of Science, Banaras Hindu University, Varanasi, India

    S. Fatma

  4. Department of Medical Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea

    M. H. Baig

  5. Faculty of Medicine, Jazan University, Jazan, Saudi Arabia

    J. Iqbal

Authors
  1. J. M. Ashraf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. M. S. Abdullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Fatma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. H. Baig
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. M. Madkhali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. B. A. Jerah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. M. Ashraf.

Additional information

Published in Russian in Biokhimiya, 2017, Vol. 82, No. 5, pp. 776-785.

Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM16-333, February 6, 2017.

To whom correspondence should be addressed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ashraf, J.M., Abdullah, S.M.S., Ahmad, S. et al. Prevalence of autoantibodies against 3-DG-glycated H2A protein in type 2 diabetes. Biochemistry Moscow 82, 579–586 (2017). https://doi.org/10.1134/S0006297917050066

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006297917050066

Keywords

Search

Navigation